Pharmaceutical Industry Wastewater Treatment
ETP, ZLD, advanced oxidation, and MBR systems for API manufacturers, formulation plants, and bulk drug producers — CPCB/PCB compliant systems for India's pharma clusters
Industry Overview
Pharmaceutical Industry Wastewater Treatment
The pharmaceutical industry generates some of the most complex industrial wastewater in India. API (Active Pharmaceutical Ingredient) manufacturing plants produce effluent containing residual pharmaceutical compounds, reaction solvents, reagents, intermediates, and high organic loads — often with components that are toxic or inhibitory to conventional biological treatment. For formulation plants and bulk drug manufacturers, the challenge is different but significant: equipment washing water, coating solvents, and process water carry pharmaceutical residues that require treatment before discharge.
Spans Envirotech designs pharmaceutical ETPs for the full spectrum of pharma manufacturing — API production, bulk drug synthesis, formulation (tablets, capsules, liquids, injectables), CRAMS facilities, and packaging operations. Our systems integrate advanced oxidation pre-treatment to break down refractory organics, biological treatment with biomass-protective process design, activated carbon polishing, and Reverse Osmosis with thermal evaporation for ZLD compliance.
We serve pharmaceutical clients across India's major pharma clusters — Hyderabad (HIIA), Ahmedabad, Ankleshwar, Baddi (Himachal Pradesh), Pune, Vapi, Mumbai, and Vizag. With CPCB and SPCB increasingly enforcing ZLD mandates on pharmaceutical units, proper pharma ETP design is a business-critical requirement, not an optional compliance measure. Schedule M GMP compliance also requires documented, effective effluent management at all drug manufacturing facilities.
Industry Challenges
Key Environmental Challenges
Complex Refractory Organics and API Residues
API manufacturing effluent contains complex organic compounds, pharmaceutical intermediates, and residual APIs that resist conventional biological degradation. Advanced oxidation (Fenton, ozone, or catalytic) is required to break down these refractory compounds before biological stages, preventing process inhibition and ensuring consistent effluent quality.
High Solvent Loading
Many API synthesis routes use organic solvents — methanol, acetone, ethyl acetate, DMF, toluene — that appear in effluent wash streams. High solvent COD can inhibit biological treatment and may require upstream solvent recovery (distillation, steam stripping) before treatment. Proper solvent handling also reduces fire risk and recovers valuable material.
High TDS and Salt Loading
Reaction workup, crystallization, and purification steps in API manufacturing generate high-TDS effluent streams containing sodium chloride, sodium sulfate, and other salts. High TDS inhibits biological treatment and is difficult to remove without RO or evaporation. ZLD systems must concentrate and manage salt-rich reject streams.
CPCB/SPCB ZLD Mandates
The CPCB and state PCBs mandate ZLD for large pharmaceutical units in Telangana, Gujarat, Himachal Pradesh, and Maharashtra. Non-compliance risks consent-to-operate suspension, criminal liability, and reputational damage. ETP design must account for ZLD from the outset — retrofitting ZLD onto an inadequately designed ETP is expensive and often unsuccessful.
Schedule M GMP Compliance
Schedule M (Good Manufacturing Practices) under the Drugs and Cosmetics Act requires pharmaceutical units to have documented, effective effluent treatment systems. Regulatory inspections from the CDSCO or state drug controllers may include ETP review. Systems must be well-documented, maintained, and demonstrate consistent compliance.
Antibiotic Resistance Gene (ARG) Contamination Risk
Effluent from antibiotic API manufacturers carrying sub-therapeutic antibiotic concentrations is a significant public health concern recognised by WHO. Proper treatment — particularly advanced oxidation and activated carbon — reduces antibiotic residues in discharged effluent and demonstrates responsible manufacturing practice for export market qualification.
Our Solutions
Tailored Wastewater Treatment Solutions
Multi-Stage Pharma ETP with Advanced Oxidation
Integrated ETP covering equalization, pH correction, Fenton or catalytic oxidation for refractory organic removal, MBBR or activated sludge biological treatment, secondary clarification, activated carbon filtration, and tertiary polishing. Designed specifically for API and formulation plant effluent profiles. CPCB/SPCB compliant.
Zero Liquid Discharge (ZLD) Systems
End-to-end ZLD systems for pharma units: ETP pre-treatment → Multi-pass RO → Thermal evaporation (MEE/MVR) → ATFD (Agitated Thin Film Dryer) for crystallisation. Designed for CPCB ZLD mandates in Hyderabad, Ahmedabad, Baddi, and other pharma clusters. Water recovery 90–98%.
Fenton Oxidation and Advanced Oxidation Processes
Fenton's reagent (hydrogen peroxide + ferrous sulfate) and advanced oxidation processes (AOP) break down complex pharmaceutical organics, decolour effluent, and reduce toxicity before biological treatment. Critical pre-treatment for API manufacturing effluent to enable reliable biological stage performance.
MBR Systems for High-Quality Permeate
Membrane Bioreactor (MBR) systems for formulation plants and pharmaceutical facilities requiring high-quality treated effluent for RO pre-treatment or water reuse. MBR produces consistently clarified permeate (TSS <1 mg/L) enabling efficient RO operation in ZLD trains.
Solvent Recovery Systems
Steam stripping and distillation columns for solvent recovery from high-solvent API manufacturing effluent streams. Recovering solvents reduces COD load on the ETP, reduces chemical oxygen demand, and recovers commercially valuable solvents — improving project economics.
ETP Upgrades and CPCB Compliance Audits
Assessment and upgrade of existing pharma ETPs to meet current CPCB/PCB standards, add ZLD capability, or correct process deficiencies. Includes effluent characterisation, gap analysis against discharge standards, design of upgrades, and commissioning of new treatment stages into existing infrastructure.
Technologies
Proven Technologies for Your Industry
Benefits
Why Choose Spans for Your Industry
- Specialist pharmaceutical ETP design — API, formulation, bulk drug, and CRAMS facilities
- CPCB/SPCB compliant systems designed for ZLD mandates in Hyderabad, Ahmedabad, Baddi, and Pune pharma clusters
- Advanced oxidation pre-treatment for refractory pharmaceutical organics
- Schedule M GMP-aligned ETP documentation for regulatory audits
- Proven ZLD systems achieving 90–98% water recovery from complex pharma effluent
- Solvent recovery integration to reduce ETP load and recover valuable materials
- Turnkey design, supply, civil coordination, and commissioning
- Effluent characterisation and treatability studies available for new API processes
- Upgrade services for ETPs failing CPCB/PCB compliance
- Post-commissioning O&M support and annual maintenance contracts
Ready to Transform Your Pharmaceutical Industry Wastewater Treatment Operations?
Let our experts design a custom solution for your facility.